What Ceban Pharmaceuticals does

Ceban Pharmaceuticals is a Dutch-headquartered international specialty pharma platform serving local healthcare providers in the Netherlands, Belgium, and Spain. The group operates eight subsidiaries spanning the pharmaceutical value chain: API/raw materials distribution (Magis Pharma in Belgium, Metapharmaceutical in Spain), central GMP compounding pharmacy services (Ceban Compounding, Meppel), pharmacy retail through the owned Medsen Apotheek collective (~50 pharmacies), hospital and clinic supply (Ceban Clinic Services, 200+ hospitals), medicine and diagnostics distribution (Bipharma), home administration of specialist medicines and patient coaching (Ceban HomeCare, 55+ BIG-registered nurses), and pharmacy automation hardware (Pharmaself24 vending machines, Q-Manager queue systems, narrowcasting — Ceban Automation). Ceban's core proposition is personalised medication preparation for vulnerable patients (e.g. children) whose needs are not commercially served by large pharma manufacturers, combined with integrated back-office and automation services for independent pharmacies.

The company runs a B2B, sales-led go-to-market targeting pharmacies, hospital pharmacies, clinics, and laboratories via direct field sales, supported by an inbound website and newsletter funnel. Revenue is generated through transaction-fee streams (compounding supply, raw materials distribution, medicine/diagnostics distribution, hospital supply), hardware sales plus service for pharmacy automation, and professional services for home care. Pricing is not publicly disclosed and is quote-based across most lines. Operationally, the platform handles 500+ pharmaceutical raw materials, produces 15,000 personalised medication preparations per year, performs 20,000 specialist home procedures annually, and reaches 4 million patients through installed vending machines.

In June 2024, Ceban Pharmaceuticals B.V. was acquired by Medios AG, a publicly-listed German Specialty Pharma solutions provider, following NZa regulatory approval and Works Council advice; prior to that, Bencis Capital Partners had been the financial investor since 2019, having backed a multi-year buy-and-build strategy that built the eight-company group from a domestic wholesale/pharmacy heritage dating back to 1980 (as Regifarm).

Name

Ceban Pharmaceuticals

Legal name

Ceban Pharmaceuticals B.V.

Website

https://cebanpharma.com

Company type

Private

Founded year

1980

Operating status

Acquired

Headcount range

251–500 employees

Short description

Ceban Pharmaceuticals is a Dutch-based specialty pharma platform operating eight subsidiaries across the Netherlands, Belgium, and Spain, delivering compounded medicines, APIs, pharmacy automation, hospital supply, and home care to 200+ hospitals and 3,300+ pharmacies.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmacies and Drug Retailers (456110)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

akta.pro secondary industries

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC), Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Pharmaceutical compounding
• Specialty pharmaceuticals
• Pharmacy automation
• Pharmaceutical distribution
• Home healthcare services

Headquarters

HQ city

Breda

HQ country

Netherlands

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Compounding pharmacy services: Supply of customised medicines to dispensing pharmacies in Netherlands and Belgium. Central compounding pharmacy preparing medicines the pharmaceutical industry does not produce commercially.
2. Pharmaceutical raw materials distribution: Distribution of APIs (active pharmaceutical ingredients) to support pharmacies in magistral preparation of custom-made medicines
3. Specialized medicines distribution: Distribution of limited-access medicines and medical diagnostics through Bipharma subsidiary
4. Home healthcare services: Home administration of specialist medicines, patient coaching, vaccination programmes and prick accident handling through Ceban HomeCare
5. Pharmacy automation solutions: Sale and service of Pharmaself24 vending machines, Q-Manager queue systems and narrowcasting solutions to pharmacies
6. Hospital pharmacy services: Supply of medicines and medical supplies to clinics and independent treatment centers through Ceban Clinic Services

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

Ceban Pharmaceuticals operates an international pharmaceutical platform providing compounding of customised medicines, distribution of pharmaceutical raw materials (APIs), pharmacy automation solutions, hospital pharmacy services, and home-based specialist medication administration. The group serves 200+ hospitals and 3,300+ pharmacies across the Netherlands, Belgium and Spain through eight operating companies, including GMP-certified production facilities, an owned pharmacy chain of ~50 outlets, and a nurse network performing 20,000+ home procedures annually.

Product overview

Ceban Pharmaceuticals is a growing international healthcare platform offering pharmaceutical solutions for local healthcare providers across the Netherlands, Belgium, and Spain. The company operates a platform-plus-subsidiaries architecture consisting of 8 companies. The core offerings include Ceban Compounding (central GMP compounding pharmacy preparing customized medicines), Ceban Automation (Pharmaself24, Q-Manager, Pharma Channel for pharmacy automation), and Ceban Clinic Services (national hospital pharmacy). Subsidiary brands include Medsen Apotheek (chain of ~50 pharmacies), Magis Pharma (Belgian API distributor), Metapharmaceutical (Spanish pharmaceutical raw materials producer), Bipharma (medicine and diagnostic distributor), and Ceban HomeCare (home medication administration services). The platform serves over 200 hospitals and 3,300 pharmacies, delivering 15,000 personalized medication preparations annually, with 600 employees across 8 companies.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 15,000 personalised medication preparations per year
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators13 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Medios AG: German listed Specialty Pharma platform and Ceban's acquirer (June 2024). Directly comparable on compounding, patient-individual therapies, and specialty distribution across Germany, Netherlands, Belgium, and Spain.
• Brocacef Groep: Dutch pharmaceutical distribution, compounding, and pharmacy services company owned by PHOENIX Group; directly comparable to Ceban's Ceban Compounding, Bipharma, and Medsen Apotheek operations in the Netherlands.
• Mosadex Groep: Dutch pharmacy cooperative and pharmaceutical wholesaler with compounding and home-care services; competes head-to-head with Ceban Compounding and Ceban HomeCare in the Netherlands.
• Pluripharm: Dutch pharmaceutical full-line wholesaler serving independent pharmacies; comparable to Ceban's distribution and pharmacy-supply activities in the Netherlands.
• Eurocept Pharmaceuticals: Specialty pharma company focused on compounding, hospital pharmacy, and home-care in the Netherlands; closely mirrors Ceban's compounding, clinic services, and HomeCare model.

Broad incumbents

• PHOENIX Group: One of Europe's largest pharmaceutical wholesale and retail pharmacy groups (owns BENU Apotheek, Brocacef). Overlaps with Ceban's pharmacy wholesale, retail pharmacy (Medsen), and compounding distribution.
• McKesson Europe (formerly Celesio): European pharmaceutical distribution and pharmacy retail (Lloyds Apotheek) across multiple EU markets; a broad incumbent in the same distribution-and-pharmacy space Ceban plays in.

Emerging players

• SHOP APOTHEKE EUROPE: European online pharmacy with mail-order dispensing; an emerging channel competitor to Ceban's Medsen Apotheek retail and home-delivery services, especially for repeat prescriptions.
• DocMorris (Zur Rose Group): Online pharmacy and prescription mail-order platform in Netherlands/Germany/Spain; competes with Medsen Apotheek's online ordering and 24/7 automated dispensing channel.

Regional players

• Caldic (Advent International): European specialty ingredients and pharma raw materials distributor; comparable to Magis Pharma and Metapharmaceutical in API/excipient distribution to compounding pharmacies and hospitals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/cebanpharma
• LinkedInlinkedin.com/company/ceban-bv

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ceban Pharmaceuticals